Serotonin reuptake inhibitors
AssigneeTheravance Biopharma R&D IP, LLC
InventorsEric L. Stangeland, Lori Jean Patterson, Daisuke Roland Saito
Life of this patent
Estimating the term…
Abstract
In one aspect, the invention relates to compounds of formula I: where X, Y, R1, R2, R3, R4, R4, and n are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
Claims2
A composition comprising the compound of formula:
- and having said configuration or enriched in a stereoisomeric form having said configuration.
A composition comprising a pharmaceutically acceptable salt of the compound of formula:
- and having said configuration or enriched in a stereoisomeric form having said configuration.
Dependencies are inferred from the claim text.